She was also noted for HSV infection positive in the past, but there were no active lesions at the time of delivery, and she continued on acyclovir suppressive therapy.
Prenatal screens were noted as follows:  Blood type A positive, antibody screen negative, hepatitis B surface antigen negative, rapid plasma reagin nonreactive, rubella immune, GBS unknown.
ANTENATAL HISTORY:  Estimated date of delivery [**2106-2-10**], for estimated gestational age of 24-6/7 weeks at delivery.
Mother received antibiotic therapy on admission for latency and again on the day of delivery for suspected chorioamnionitis.
She received a full course of betamethasone one week before delivery.
She progressed to a spontaneous vaginal delivery under epidural anesthesia.
NEONATAL COURSE:  Infant emerged with inconsistent respiratory effort and bradycardia to 40 beats per minute.
She was orally and nasally bulb-suctioned dried and given Neopuff manual ventilation, with PIP incrementally increased to 28 cm of water.
She was started on high- frequency oscillatory ventilator (HFOV) with a MAP of 12.
She was normocephalic, 2.5 oral ET tube in place.
She was initially intubated in the     delivery room, and was started on high-frequency     oscillatory ventilation.
She continued to wean on the ventilator     and was transferred to nasal CPAP on day of life 4, and     she continued on CPAP from day of life 4 to day of life     17.
She was transitioned again to CPAP on day of     life 31, where she continued to day of life 50, and on     day of life 50 she was transitioned to nasal cannula     oxygen, and she remained on nasal cannula 13 to 25 mL,     with occasional apnea and bradycardia at the time of     transfer.
She was     also started on caffeine on day of life 2, which was     discontinued on day of life 71, given decrease in the     amount of spell.
She also received vitamin A, 12 doses     intramuscularly.
She was initially noted to have     some hemodynamic instability, and concern for an open     persistent ductus arteriosus, and she was treated with     indomethacin treatment with 3 doses.
Umbilical lines were placed initially, and she was     NPO and started on parenteral nutrition from day of life     1.
Umbilical lines were discontinued on day of life 7,     and a PICC line was placed, which remained from day of     life 7 to 30.
On day of life 16, she was noted to have     increased spells of abdominal distension, and she was     made NPO and serial KUBs were performed, which were     negative for any evidence of necrotizing enterocolitis.
She was also started on vancomycin and Gentamycin during     these episodes.
She remained hemodynamically stable     with normal KUB, and feeds were restarted on day of life     19.
She is also     noted to have mild puffiness, and she received one dose     of Lasix on [**1-10**], with some improvement in her     edema.
She     was also started on ferrous sulfate and vitamin E     supplementation on day of life 15, and this continued at     the time of transfer.
An initial blood culture was     performed at birth, and she was started on ampicillin     and Gentamycin.
Her spinal tap was negative on day of     life 3, and she received a 7-day course of antibiotics,     given the concern for maternal chorioamnionitis and     pneumonia on the baby.
She was noted to have increased     spells with abdominal distention on day of life 16, on     [**2105-11-12**], and was started on vancomycin and     gentamicin, with acyclovir added given maternal     HSV colonization and acyclovir treatment.
She continued on     vancomycin and ceftazidime from day of life 20 to day of     life 25 for a 7-day course.
Vitamin E 5 international units per day.
IRON AND VITAMIN D SUPPLEMENTATION: 1.
Iron supplementation is recommended for preterm and low     birth weight infants until 12 months corrected age.
IMMUNIZATIONS:  She received her 2-month vaccines on [**2105-12-29**].
IMMUNIZATIONS RECOMMENDED: 1.
Synagis respiratory syncytial virus prophylaxis should     be considered from [**Month (only) **] through [**Month (only) 958**], for infants     who meet any of the following four criteria:  (a) born     at less than 32 weeks; (b) born between 32 and 35 weeks     with two of the following: Day care during RSV season,     a smoker in the house, neuromuscular disease,     airway abnormalities, or school-age siblings; (c)     chronic lung disease; or (d) hemodynamically-significant     congential heart disease.
Influenza immunization is recommended early in the fall     for all infants once they reach 6 months of age.
Before     this age, and for the first 24 months of the child's     life, immunization against influenza is recommended for     household contacts and out-of-home caregivers.
This infant has not received rotavirus vaccine.
PDA treated with Indomethacin.
